Dr. Ali Abou Yassine, M.D
NPI: 1689953846
Total Payments
$420.29
2021 Payments
$11.92
Companies
7
Transactions
24
Medicare Patients
1,198
Medicare Billing
$148,497
Payment Breakdown by Category
Food & Beverage$370.37 (88.1%)
Education$49.92 (11.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $370.37 | 22 | 88.1% |
| Education | $49.92 | 2 | 11.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $136.66 | 9 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $82.78 | 5 | $0 (2019) |
| Grifols USA, LLC | $60.95 | 3 | $0 (2019) |
| Genentech USA, Inc. | $58.31 | 2 | $0 (2019) |
| Philips Electronics North America Corporation | $54.07 | 3 | $0 (2019) |
| Shire North American Group Inc | $15.60 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $169.46 | 10 | Philips Electronics North America Corporation ($54.07) |
| 2018 | $155.10 | 8 | GlaxoSmithKline, LLC. ($71.39) |
| 2017 | $83.81 | 5 | Grifols USA, LLC ($42.32) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Education | In-kind items and services | $11.92 | General |
| Category: COVID-19 | ||||||
| 10/09/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Pulmonology | ||||||
| 09/11/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 08/07/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2019 | Shire North American Group Inc | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Respiratory | ||||||
| 06/12/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/05/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Respiratory | ||||||
| 12/13/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Respiratory | ||||||
| 10/04/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ARNUITY | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Respiratory | ||||||
| 02/22/2018 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
| 01/19/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Respiratory | ||||||
| 12/13/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Pulmonology | ||||||
| 10/31/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug), BREO | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 201 | 299 | $97,859 | $29,747 |
| 2022 | 10 | 338 | 450 | $97,524 | $34,091 |
| 2021 | 13 | 369 | 463 | $115,584 | $34,430 |
| 2020 | 10 | 290 | 445 | $184,493 | $50,229 |
Total Patients
1,198
Total Services
1,657
Medicare Billing
$148,497
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 51 | 115 | $80,155 | $19,521 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 93 | $9,021 | $6,875 | 76.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 37 | $4,832 | $2,306 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $1,893 | $756.67 | 40.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 14 | 14 | $821.00 | $121.55 | 14.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 15 | 15 | $967.00 | $90.48 | 9.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 14 | 14 | $170.00 | $76.92 | 45.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 45 | 94 | $65,518 | $15,617 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 105 | $10,186 | $7,190 | 70.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 48 | $4,560 | $3,429 | 75.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $2,945 | $2,048 | 69.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 41 | $4,469 | $2,027 | 45.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,640 | $1,279 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $1,860 | $1,274 | 68.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 16 | $1,006 | $754.51 | 75.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 27 | 28 | $1,802 | $161.21 | 8.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 30 | 31 | $1,959 | $130.04 | 6.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 28 | 29 | $369.00 | $98.97 | 26.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 15 | 15 | $210.00 | $82.66 | 39.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 67 | 119 | $82,068 | $20,177 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 53 | $5,717 | $3,851 | 67.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 46 | $5,014 | $2,614 | 52.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $3,138 | $1,507 | 48.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 20 | $2,212 | $1,277 | 57.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $2,655 | $1,196 | 45.0% |
About Dr. Ali Abou Yassine, M.D
Dr. Ali Abou Yassine, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689953846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Abou Yassine, M.D has received a total of $420.29 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($370.37).
As a Medicare-enrolled provider, Abou Yassine has provided services to 1,198 Medicare beneficiaries, totaling 1,657 services with total Medicare billing of $148,497. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Critical Care Medicine
- Location Staten Island, NY
- Active Since 08/05/2011
- Last Updated 06/07/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1689953846
Products in Payments
- SYMBICORT (Drug) $82.78
- TRELEGY ELLIPTA (Drug) $69.76
- inCourage (Device) $54.07
- Prolastin-C (Biological) $42.32
- Esbriet (Biological) $38.00
- NUCALA (Biological) $36.55
- Xolair (Biological) $20.31
- Prolastin-C Liquid (Biological) $18.63
- INCRUSE (Drug) $17.66
- GLASSIA (Biological) $15.60
- ANORO (Drug) $12.69
- Veklury (Drug) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Staten Island
Dr. Elizabeth Lulaj, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $47,200
Student in an Organized Health Care Education/Training Program $47,200
Dr. Samer Saouma, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,327
Student in an Organized Health Care Education/Training Program $31,327
Dr. Philippe Akhrass, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $14,172
Student in an Organized Health Care Education/Training Program $14,172
Gledi Peco, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $7,295
Student in an Organized Health Care Education/Training Program $7,295
Anna Nemeth
Student in an Organized Health Care Education/Training Program — Payments: $3,847
Student in an Organized Health Care Education/Training Program $3,847
Chadi Salmane
Student in an Organized Health Care Education/Training Program — Payments: $3,597
Student in an Organized Health Care Education/Training Program $3,597